A patient’s prognosis for BRCA1/2-related cancer depends on the stage at which the cancer is diagnosed and on the type of mutation; however, studies of survival have revealed conflicting information for individuals with germline BRCA1 or BRCA2 pathogenic variants when compared to controls. The gene discussed is BRCA1; the disease is cancer.